Company profile: Vigene Biosciences
1.1 - Company Overview
Company description
- Provider of gene delivery technologies and cell and gene therapy CDMO solutions, offering research- and cGMP-grade AAV, lentivirus, and adenovirus products and custom services, including ready-to-ship genome-wide human cDNA ORFs on adenoviral or lentiviral, supporting therapy development and production to advance biomedical research and make gene therapy affordable.
Products and services
- Viral Vector Products: cGMP-grade AAV, lentivirus, and adenovirus-based products, also available research-grade, supporting gene delivery for biomedical research and affordable gene therapy development
- Cell and Gene Therapy CDMO Services: custom-engineered contract development and manufacturing services for cell and gene therapy, supporting the development and production of therapies
- Genome-wide Human cDNA ORFs Library: genome-wide, ready-to-ship human cDNA ORFs packaged on adenoviral or lentiviral vectors, enabling streamlined gene delivery for biomedical research initiatives
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vigene Biosciences
GeneInsight
HQ: United States
Website
- Description: Provider of an IT platform that streamlines data interpretation and management; GeneInsight Suite has been in clinical use and evolving since 2005, developed at Partners HealthCare in collaboration with leading geneticists, laboratory operations personnel, practicing physicians, and IT professionals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GeneInsight company profile →
Crescendo Bioscience
HQ: United States
Website
- Description: Provider of quantitative, objective diagnostic tools for rheumatologists, delivering clinical insights to manage patients with autoimmune and inflammatory diseases. Provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Crescendo Bioscience company profile →
NuGEN
HQ: United States
Website
- Description: Provider of innovative genomics sample preparation solutions enabling scientists to access true biology in all samples, independent of type, quality and amount, for analysis on leading analytical platforms, ensuring robust and reproducible results for researchers seeking to predict disease
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuGEN company profile →
Guide Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology solutions addressing delivery of genetic therapies, leveraging patented technologies to test thousands of chemically distinct nanoparticles in vivo to identify simple, scalable, clinically relevant nanoparticles that target new cell types efficiently and safely.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Guide Therapeutics company profile →
RareCyte
HQ: United States
Website
- Description: Provider of rare cell characterization and isolation solutions for life science research and diagnostic development, including the Orion Platform for whole slide multimodal imaging in spatial biology and biomarker quantitation; CyteFinder II for high-speed imaging with multiplexed liquid biopsy and tissue spatial analysis and single-cell or tissue micro-region retrieval; AccuCyte for isolating circulating tumor cells; Precision Biology Services; and customizable Orion biomarker panels for FFPE or frozen tissue.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RareCyte company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vigene Biosciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vigene Biosciences
2.2 - Growth funds investing in similar companies to Vigene Biosciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vigene Biosciences
4.2 - Public trading comparable groups for Vigene Biosciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →